[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mineralys Therapeutics Inc (MLYS)

Mineralys Therapeutics Inc (MLYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mineralys Therapeutics Inc 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 USA

www.mineralystx.com Employees: 76 P: 888-378-6240

Sector:

Medical

Description:

Mineralys Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Mineralys Therapeutics Inc. is based in RADNOR, Pa.

Key Statistics

Overview:

Market Capitalization, $K 2,452,666
Enterprise Value, $K 2,279,746
Shares Outstanding, K 82,498
Float, K 66,873
% Float 81.06%
Short Interest, K 8,778
Short Float 10.65%
Days to Cover 6.51
Short Volume Ratio 0.58
% of Insider Shareholders 18.94%
% of Institutional Shareholders 84.46%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -154,650 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -39,340 K
EBIT, $ -171,500 K
EBITDA, $ -171,440 K

Growth:

1-Year Return 94.94%
3-Year Return 91.68%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.47 on 05/06/26
Next Earnings Date 08/11/26
Earnings Per Share ttm -2.05
EPS Growth vs. Prev Qtr -17.50%
EPS Growth vs. Prev Year 40.51%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

MLYS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -27.92%
Return-on-Assets % -26.98%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 3.82
Book Value/Share 7.74
Interest Coverage -3.01
60-Month Beta 0.49
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.